Holdings (as at 2025-11-07)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
Insmed Incorporated 2.88%
Incyte Corporation 2.73%
Regeneron Pharmaceuticals, Inc. 2.56%
Globus Medical, Inc. (Class A) 2.56%
Medpace Holdings, Inc. 2.51%
Ionis Pharmaceuticals, Inc. 2.46%
Universal Health Services, Inc. (Class B) 2.45%
Biogen Inc. 2.43%
United Therapeutics Corporation 2.34%
Centene Corporation 2.30%
Illumina, Inc. 2.25%
Pfizer Inc. 2.10%
BioMarin Pharmaceutical Inc. 2.08%
Avantor, Inc. 2.02%
HCA Healthcare, Inc. 1.96%
Tempus AI, Inc. (Class A) 1.94%
Neurocrine Biosciences, Inc. 1.90%
Elanco Animal Health Incorporated 1.87%
Merck & Co., Inc. 1.80%
Molina Healthcare, Inc. 1.74%
Elevance Health Inc. 1.72%
Acadia Healthcare Company, Inc. 1.72%
Alnylam Pharmaceuticals, Inc. 1.70%
Abbott Laboratories 1.65%
Halozyme Therapeutics, Inc. 1.63%
The Cigna Group 1.61%
Zimmer Biomet Holdings, Inc. 1.57%
Teleflex Incorporated 1.56%
IDEXX Laboratories, Inc. 1.45%
Royalty Pharma Plc (Class A) 1.44%
Bio-Rad Laboratories, Inc. (Class A) 1.43%
Henry Schein, Inc. 1.42%
Align Technology, Inc. 1.41%
Bristol-Myers Squibb Company 1.36%
Tenet Healthcare Corporation 1.33%
Johnson & Johnson 1.32%
Exelixis, Inc. 1.30%
Veeva Systems Inc. (Class A) 1.30%
Doximity, Inc. (Class A) 1.30%
GE HealthCare Technologies Inc. 1.28%
Humana Inc. 1.27%
Quest Diagnostics Incorporated 1.24%
UnitedHealth Group Incorporated 1.23%
Cardinal Health, Inc. 1.14%
Organon & Co. 1.11%
Hologic, Inc. 0.96%
Gilead Sciences, Inc. 0.94%
Revvity, Inc. 0.91%
Insulet Corporation 0.91%
The Cooper Companies, Inc. 0.89%
Sotera Health Company 0.87%
Medtronic Plc 0.85%
Perrigo Company Plc 0.85%
QIAGEN N.V. 0.85%
Chemed Corporation 0.85%
Becton, Dickinson and Company 0.83%
AbbVie Inc. 0.83%
ResMed Inc. 0.81%
Corcept Therapeutics Inc. 0.78%
Apellis Pharmaceuticals, Inc. 0.74%
Waters Corporation 0.51%
Natera, Inc. 0.51%
Exact Sciences Corporation 0.50%
Thermo Fisher Scientific Inc. 0.48%
Amgen Inc. 0.47%
Agilent Technologies, Inc. 0.47%
IQVIA Holdings Inc. 0.46%
Edwards Lifesciences Corporation 0.44%
Steris Plc 0.44%
Penumbra, Inc. 0.43%
Envista Holdings Corporation 0.39%
Sarepta Therapeutics, Inc. 0.38%
Encompass Health Corporation 0.37%
Labcorp Holdings Inc. 0.36%
Zoetis Inc. 0.34%
Baxter International Inc. 0.32%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.